These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 18311493)
1. The effect of modafinil following acute CPAP withdrawal: a preliminary study. Williams SC; Rogers NL; Marshall NS; Leung S; Starmer GA; Grunstein RR Sleep Breath; 2008 Nov; 12(4):359-64. PubMed ID: 18311493 [TBL] [Abstract][Full Text] [Related]
2. Modafinil effects during acute continuous positive airway pressure withdrawal: a randomized crossover double-blind placebo-controlled trial. Williams SC; Marshall NS; Kennerson M; Rogers NL; Liu PY; Grunstein RR Am J Respir Crit Care Med; 2010 Apr; 181(8):825-31. PubMed ID: 20056901 [TBL] [Abstract][Full Text] [Related]
3. Modafinil Increases Awake EEG Activation and Improves Performance in Obstructive Sleep Apnea during Continuous Positive Airway Pressure Withdrawal. Wang D; Bai XX; Williams SC; Hua SC; Kim JW; Marshall NS; D'Rozario A; Grunstein RR Sleep; 2015 Aug; 38(8):1297-303. PubMed ID: 26158894 [TBL] [Abstract][Full Text] [Related]
4. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial. Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166 [TBL] [Abstract][Full Text] [Related]
5. Placebo and modafinil effect on sleepiness in obstructive sleep apnea. Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628 [TBL] [Abstract][Full Text] [Related]
6. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Black JE; Hirshkowitz M Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291 [TBL] [Abstract][Full Text] [Related]
7. Modafinil improves functional outcomes in patients with residual excessive sleepiness associated with CPAP treatment. Weaver TE; Chasens ER; Arora S J Clin Sleep Med; 2009 Dec; 5(6):499-505. PubMed ID: 20465014 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic approaches for the management of symptoms and cardiovascular consequences of obstructive sleep apnea in adults. Dopp JM; Morgan BJ Sleep Breath; 2010 Dec; 14(4):307-15. PubMed ID: 20582741 [TBL] [Abstract][Full Text] [Related]
9. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study. Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422 [TBL] [Abstract][Full Text] [Related]
10. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea. Roth T; Rippon GA; Arora S Sleep Breath; 2008 Mar; 12(1):53-62. PubMed ID: 17874255 [TBL] [Abstract][Full Text] [Related]
11. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure. Inoue Y; Miki M; Tabata T Sleep Med; 2016; 27-28():45-48. PubMed ID: 27938918 [TBL] [Abstract][Full Text] [Related]
12. Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP. Dinges DF; Weaver TE Sleep Med; 2003 Sep; 4(5):393-402. PubMed ID: 14592280 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study. Inoue Y; Takasaki Y; Yamashiro Y J Clin Sleep Med; 2013 Aug; 9(8):751-7. PubMed ID: 23946704 [TBL] [Abstract][Full Text] [Related]
14. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Schwartz JR; Hirshkowitz M; Erman MK; Schmidt-Nowara W Chest; 2003 Dec; 124(6):2192-9. PubMed ID: 14665500 [TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Kingshott RN; Vennelle M; Coleman EL; Engleman HM; Mackay TW; Douglas NJ Am J Respir Crit Care Med; 2001 Mar; 163(4):918-23. PubMed ID: 11282766 [TBL] [Abstract][Full Text] [Related]
16. Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study. Hirshkowitz M; Black J CNS Drugs; 2007; 21(5):407-16. PubMed ID: 17447828 [TBL] [Abstract][Full Text] [Related]
17. The 5-min pupillary alertness test is sensitive to modafinil: a placebo controlled study in patients with sleep apnea. Nikolaou A; Schiza SE; Giakoumaki SG; Roussos P; Siafakas N; Bitsios P Psychopharmacology (Berl); 2008 Feb; 196(2):167-75. PubMed ID: 17899016 [TBL] [Abstract][Full Text] [Related]
18. Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder. Keating GM; Raffin MJ CNS Drugs; 2005; 19(9):785-803. PubMed ID: 16142993 [TBL] [Abstract][Full Text] [Related]
19. Effects of armodafinil on simulated driving and self-report measures in obstructive sleep apnea patients prior to treatment with continuous positive airway pressure. Kay GG; Feldman N J Clin Sleep Med; 2013 May; 9(5):445-54. PubMed ID: 23674935 [TBL] [Abstract][Full Text] [Related]
20. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]